Comparison of MR Enteroclysis and MRI With Per Oral Contrast Using a 6 % Mannitol Solution.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00204165
Recruitment Status : Unknown
Verified September 2006 by University of Oslo.
Recruitment status was:  Active, not recruiting
First Posted : September 20, 2005
Last Update Posted : September 11, 2006
Information provided by:
University of Oslo

Brief Summary:
The purpose of this study is to compare MRI enteroclysis with MRI of the small bowel with a per oral 6%mannitol solution.Our hypothesis is that the peroral technique preform the same way as MRI Enteroclysis.

Condition or disease Intervention/treatment Phase
Magnetic Resonance Imaging, Intestine Small, Crohn Disease. Procedure: MRI of the small bowel Phase 3

Study Type : Interventional  (Clinical Trial)
Enrollment : 40 participants
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: None (Open Label)
Primary Purpose: Diagnostic
Official Title: MRI of the Small Bowel. Comparison of Different Techniques and Contrast.
Study Start Date : November 2004
Study Completion Date : June 2005

Resource links provided by the National Library of Medicine

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • above 18 years
  • known Crohns disease or strong suspicion.
  • need of a small bowel examination

Exclusion Criteria:

  • pregnant
  • electrolyte disturbances.
  • Any MRI contraindications.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00204165

Ulleval Universitets sykehus
Kirkeveien 166, Oslo, Norway, 0407
Sponsors and Collaborators
University of Oslo
Study Director: Nils-Einar Kløw, Prof. MD Ulleval Universitetssykehus Identifier: NCT00204165     History of Changes
Other Study ID Numbers: 431-04150
First Posted: September 20, 2005    Key Record Dates
Last Update Posted: September 11, 2006
Last Verified: September 2006

Additional relevant MeSH terms:
Crohn Disease
Inflammatory Bowel Diseases
Gastrointestinal Diseases
Digestive System Diseases
Intestinal Diseases